Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Epimmune Enters Agreement For $13.5M Stock Merger With Anosys

May 13, 2003

By Aaron Lorenzo

Epimmune Enters Agreement For $13.5M Stock Merger With Anosys

May 13, 2003

By Aaron Lorenzo

Symyx Spins Off Therapeutics Group, Secures $8M Financing

May 12, 2003

By Aaron Lorenzo

Symyx Spins Off Therapeutics Group, Secures $8M Financing

May 12, 2003

By Aaron Lorenzo

Guilford Licenses Inhibitor Class To Pfizer As Part Of Broad Deal

May 9, 2003

By Aaron Lorenzo

Guilford Pharmaceuticals Inc. is licensing an entire class of potential neurodegenerative disease drugs to Pfizer Inc. for $5 million up front in a deal that could become much more lucrative down the road. (BioWorld Today)

Guilford Licenses Inhibitor Class To Pfizer As Part Of Broad Deal

May 9, 2003

By Aaron Lorenzo

Guilford Pharmaceuticals Inc. is licensing an entire class of potential neurodegenerative disease drugs to Pfizer Inc. for $5 million up front in a deal that could become much more lucrative down the road. (BioWorld Today)

Study Of Memantine In Pain Misses Primary Endpoints

May 8, 2003

By Aaron Lorenzo

Negative trial news Wednesday sent ripples through companies involved in the development of memantine. (BioWorld Today)

Study Of Memantine In Pain Misses Primary Endpoints

May 8, 2003

By Aaron Lorenzo

Negative trial news Wednesday sent ripples through companies involved in the development of memantine. (BioWorld Today)

Employees Return To Genelabs As $8.1 Million Placement Closes

May 6, 2003

By Aaron Lorenzo

AVI Raises $15M Privately From Investors Who Acted In A Hurry

May 6, 2003

By Aaron Lorenzo

View All Articles by Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...